Advertisement

Neurologische Manifestationen

  • Karl M. Einhäupl
  • Eva Schielke
Conference paper

Zusammenfassung

Zwei Jahre nach Gottliebs Erstbeschreibung (1981) des erworbenen Immundefektsyndroms (AIDS) berichteten Snider et al. (1983) über neurologische Komplikationen bei 50 AIDS-Patienten. Dem folgten zahllose Einzelfalldarstellungen wie auch mehrere Untersuchungen an größeren Kollektiven, wovon insbesondere die Arbeiten von Levy et al. (1985) sowie Enzensberger u. Fischer (1987) zu erwähnen sind.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ackermann R, Nekic M, Jürgens R (1986) Locally synthesized antibodies in cerebrospinal fluid of patients with AIDS. J Neurol 233: 140–141PubMedCrossRefGoogle Scholar
  2. Albert ML, Feldmann RG, Willis AL (1974) The „subcortical dementia“ of progressive supra-nuclear palsy. J Neurol Neurosurg Psychiatry 37: 121–130PubMedCrossRefGoogle Scholar
  3. Appleman ME, Marshall DW, Brey RL et al. (1988) Cerebrospinal fluid abnormalities in pa-tients without AIDS who are seropositive for the human immunodeficiency virus. J Infect Dis 158: 193–199PubMedCrossRefGoogle Scholar
  4. Barnes DM (1987) Solo action of AIDS virus coat. Science 237: 971–973PubMedCrossRefGoogle Scholar
  5. Bennett JE, Dismukes WE, Duma RJ et al. (1979) A comparison of amphotericine B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med 301: 126–131PubMedCrossRefGoogle Scholar
  6. Berger JR, Kaszovitz B, Post JD, Dickinson G (1987) Progressive multifocal leukoencephalo-pathy associated with human immunodeficiency virus infection. Ann Int Med 107: 78–87PubMedGoogle Scholar
  7. Berger JR, Moskowitz L, Fischl M, Kelley RE (1987) Neurologic disease as the presenting manifestation of acquired immunodeficiency syndrome. South Med J 80: 683–686PubMedCrossRefGoogle Scholar
  8. Bessen LJ, Greene JF, Louie E, Seitzman P, Weinberg H (1988) Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC. N Engl J Med 318: 708PubMedGoogle Scholar
  9. Biniek R, Bartholome M, Schulz M, Lehmann HJ, Gesemann H, Scheiermann N (1988) Intrathecal production of HIV antibodies in suspected AIDS encephalopathy. J Neurol 235: 131–135PubMedCrossRefGoogle Scholar
  10. Bredesen DE, Levy RM, Rosenblum ML (1988) The neurology of human immunodeficiency virus infection. Quart J Med 68: 665–677PubMedGoogle Scholar
  11. Budka H, Constanzi G, Cristina S, Lechi A, Parravicini C, Trabattoni R, Vago L (1987) Brain pathology induced by infection with the human immunodeficiency virus ( HIV ). Acta Neuro-pathol 75: 185–198Google Scholar
  12. Carne CA, Tedder RS, Smith A et al. (1985) Acute encephalopathy coincident with seroconversion for anti-HTLV-III. Lancet II: 1206–1208Google Scholar
  13. Centers for Disease Control, Atlanta (1987) Re-vision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMW36 [Suppl 1]: 1 — 15Google Scholar
  14. Chiodi F, Norkrans G, Hagberg L et al. (1988) Human immunodeficiency virus infection of the brain. II. Detection of intrathecally synthesized antibodies by enzyme linked immunosorbent assay and imprint immunofixation. J Neurol Sei 87: 37–48Google Scholar
  15. Cornblath DR (1988) Treatment of the neuromuscular complications of human immunodeficiency virus infection. Ann Neurol 23 [Suppl]: 88 — 91CrossRefGoogle Scholar
  16. Diederich NA, Karenberg A, Peters UH (1988) Psychopathologische Bilder bei der HIV-Infektion: AIDS-Lethargie und AIDS-Demenz. Fortschr Neurol Psychiatr 56: 173–185Google Scholar
  17. Drew WL (1988) Cytomegalovirus infection in patients with AIDS. J Infect Dis 158: 449–456PubMedCrossRefGoogle Scholar
  18. Einhäupl KM, Pfister HW, Matuschke A et al. (1988) Die Bedeutung verschiedener Liquorsyndrome und neurologischer Befunde für die Diagnose der HIV-Enzephalopathie. Vortrag auf dem I. Deutschen AIDS-Kongreß, München 1988Google Scholar
  19. Elovaara I, Seppälä I, Poutiainen E, Suni J, Valle SL (1988) Intrathecal humoral immunologic response in neurologically symptomatic and asymptomatic patients with human immuno-deficiency virus infection. Neurology 308: 1451–1456Google Scholar
  20. Engstrom J, Lowenstein DH, Bredesen DE (1988) Stroke and transient neurologic deficits associated with AIDS. Neurology (American Academy of Neurology Newsletter) 1988Google Scholar
  21. Enzensberger W, Fischer PA (1987) Zentralner-vöse Befunde bei 140 Frankfurter Patienten mit HIV-Infektion. In: Fischer PA, Schlote W (Hrsg) AIDS und Nervensystem. Springer, Berlin Heidelberg New York Tokyo, S 54–63Google Scholar
  22. Enzensberger W, Fischer PA (1987) Neurological complications in AIDS. J Neurol 234: 269–279PubMedCrossRefGoogle Scholar
  23. Goudsmit E, Wolters EC, Bakker M et al. (1986) Intrathecal synthesis of antibodies to HTLV-III in patients without AIDS or AIDS related complex. Br Med J 292: 1231–1234CrossRefGoogle Scholar
  24. Fenton TW (1987) AIDS-related psychiatric disorder. Br J Psychiatry 151: 579–588PubMedCrossRefGoogle Scholar
  25. Goethe KE, Mitchell JE, Marshall DW et al. (1989) Neuropsychological and neurological function of human immunodeficiency virus se-ropositive asymptomatic individuals. Arch Neurol 46: 129–133PubMedGoogle Scholar
  26. Gold JE, Jimenez E, Zalusky R (1988) Human immunodeficiency virus-related lymphoreticu-lar malignancies and peripheral neurologic disease. Cancer 61: 2318–2324PubMedCrossRefGoogle Scholar
  27. Gorard DA, Henry K, Guiloff RF (1988) Necro-tising myopathy and zidovudine. Lancet 1: 1050CrossRefGoogle Scholar
  28. Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, Saxon A (1981) Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men. N Engl J Med 305: 1425–1431PubMedCrossRefGoogle Scholar
  29. Goudsmit J, de Wolf F, Paul DA et al. (1986) Expression of human immunodeficiency virus antigen ( HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet 11: 177–180Google Scholar
  30. Gray F, Gherardi R, Scaravilli F (1988) The neu-ropathology of the acquired immune deficiency syndrome ( AIDS ). Brain 111: 245–266Google Scholar
  31. Härtung HP, Heininger K, Toyka KV (1988) Neuromuskuläre Manifestationen der HIV–1-und HTLV-I-Infektionen. Dtsch Med Wo-chenschr 113: 1975–1981CrossRefGoogle Scholar
  32. Haverkos TE and the TE Study Group (1987) Assessment of therapy for toxoplasma encephalitis. Am J Med 82: 907–914PubMedCrossRefGoogle Scholar
  33. Heibert M, Robinson D, Peddle B, Mann J, Gore D, Stoneham C, Pinching A (1988) Treatment of patients with AIDS and AIDS-related complex with zidovudine. IVth International Conference on AIDS. Stockholm 1988Google Scholar
  34. Helweg-Larsen S, Jakobsen J, Boesen F et al. (1988) Myelopathy in AIDS. A clinical and electrophysiological study of 23 Danish patients. Acta Neurol Scand 77: 64–73PubMedCrossRefGoogle Scholar
  35. Hicks CB, Benson PM, Lupton GP, Tramont EC (1987) Seronegative secondary syphilis in a patient infected with the human immunodeficiency virus ( HIV) with Kaposi sarcoma. Ann Int Med 107: 492–495Google Scholar
  36. Ho DD, Rota RT, Schooley RT et al. (1985) Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 313: 1493–1497PubMedCrossRefGoogle Scholar
  37. Ho DD, Pomerantz RJ, Kaplan JC (1987) Pathogenesis of infection with human immunodeficiency virus. N Engl J Med 317: 278–286PubMedCrossRefGoogle Scholar
  38. Hollander H, Levy JA (1987) Neurological abnormalities and recovery of human immunodeficiency virus from cerebrospinal fluid. Ann Int Med 106: 692–695PubMedGoogle Scholar
  39. Hollander H, Stringari S (1987) Human immunodeficiency virus-associated meningitis. Am J Med 83: 813–816PubMedCrossRefGoogle Scholar
  40. Israelski DM, Tom C, Remington JS (1989) Zidovudine antagonizes the action of pyrimethamine in experimental infection with toxoplasma gondii. Antimicrob Agent Chemother 33: 30–34Google Scholar
  41. Jacome DE (1982) Neurogenic bladder, lumbo-sacral plexus neuropathy and drug-associated rhabdomyolysis. J Urol 127: 994–995PubMedGoogle Scholar
  42. Klecker RW, Collins JM, Yarchoan R, Thomas R, Jenkins JF, Broder S, Myers CE (1987) Plasma and cerebrospinal fluid pharmacokinetic of 3′-azido–3′-deoxythimidine: A novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases. Clin Pharmacol Ther 41: 407–412Google Scholar
  43. Koenig S, Gendelman HE, Orenstein JM et al. (1986) Detection of AIDS virus in macropha-ges in brain tissue from AIDS patients with en-cephalopathy. Science 233: 1089–1093PubMedCrossRefGoogle Scholar
  44. Kovacs JA, Kovacs AA, Polis M et al. (1985) Cryptococcosis in the acquired immunodefi-ciency syndrome. Ann Int Med 103: 533 — 538PubMedGoogle Scholar
  45. Lange DJ, Britton CB, Younger DS, Hay AP (1988) The neuromuscular manifestations of human immunodeficiency virus infections. Arch Neurol 45: 1084–1088PubMedGoogle Scholar
  46. Levy JA, Shimabukuro J, Hollander H, Mills J, Kaminsky L (1985) Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms. Lancet 11: 586–588Google Scholar
  47. Levy RM, Bredesen DE, Rosenblum ML (1985) Neurological manifestations of the acquired immunodeficiency syndrome: Experience at UCSF and review of the literature. J Neurosurg 62: 475–495Google Scholar
  48. Lohmöller G, Matuschke A, Goebel FD (1988) Autonome Neuropathie bei HIV-Infektion? I. Deutscher AIDS-Kongreß, München 1988 Lüer W, Poser S, Weber T, Jürgens S, Eichenlaub D, Pohle HD, Felgenhauer K (1988)Google Scholar
  49. Chronic HIV-encephalitis — I. Cerebrospinal fluid diagnosis. Klin Wochenschr 66: 21 — 28Google Scholar
  50. Maccario M, Scharre D (1987) HIV and acute on-set of psychosis. Lancet 11: 342CrossRefGoogle Scholar
  51. Marshall DW, Brey RL, Cahill WT, Houk RW, Zajac RA, Boswell RN (1988) Spectrum of cerebrospinal fluid findings in various stages of human immunodeficency virus infection. Arch Neurol 45: 954–958PubMedGoogle Scholar
  52. Matthes J, Walker LA, Watson JG, Bird AG (1988) AIDS encephalopathy with response to treatment. Arch Dis Child 63: 545–547PubMedCrossRefGoogle Scholar
  53. Miller RF, Semple SJG (1987) Autonomic neuropathy in AIDS. Lancet 11: 343–344CrossRefGoogle Scholar
  54. Mizusawa H, Hirano A, Llena JF, Shintaku M (1988) Cerebrovascular lesions in acquired im-munodeficiency syndrome ( AIDS ). Acta Neu-ropathol 76: 451–457Google Scholar
  55. Möller AA, Jäger H, Bremer D (1988) Paranoide Psychosen bei HIV-Infektion. Dtsch Med Wo-chenschr 113: 1234–1235CrossRefGoogle Scholar
  56. Monte de la SM, Ho DD, Schooley RT, Hirsch MS, Richardson EP (1987) Subacute encephalomyelitis of AIDS and its relation to HTLV-III infection. Neurology 37: 562–569Google Scholar
  57. Morgello S, Chos ES, Nielsen S, Devinsky O, Petita CK (1987) Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: An autopsy study of 30 cases and a review of the literature. Hum Pathol 18: 289–297PubMedCrossRefGoogle Scholar
  58. Naber D, Perro C, SchickU et al. (1989) Psychiatrische Symptome und neuropsychologische Auffälligkeiten bei HIV-Infizierten. Nervenarzt 60: 80–85PubMedGoogle Scholar
  59. Navia BA, Jordan BD, Price RW (1986) The AIDS dementia complex: I. Clinical features. Ann Neurol 19: 517–524Google Scholar
  60. Navia BA, Petito CK, Gold JWM, Cho ES, Jordan BD, Price RW (1986) Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: Clinical and neuropatho-logical findings in 27 patients. Ann Neurol 19: 224–238PubMedCrossRefGoogle Scholar
  61. Newsome DA, Green WR, Miller ED, Kiessling LA, Morgan B, Jabs DA, Polk BF (1984) Microvascular aspects of acquired immune deficiency syndrome retinopathy. Am J Ophthalmol 98: 590–601PubMedGoogle Scholar
  62. Petito CK, Navia BA, Cho ES, Jordan BD, George DC, Price RW (1985) Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med 312: 874–879PubMedCrossRefGoogle Scholar
  63. Pfister HW, Einhäupl KM, Büttner U, Goebel FD, Matuschke A, Schielke E, Fröschl M (1989) Dissociated nystagmus as a common sign of oculomotor disorders in HIV infected patients. Eur Neurol (in press)Google Scholar
  64. Pizzo PA, Eddy J, Falloon J et al. (1988) Effect of continuous intravenous infusion of zidovudine in children with symptomatic HIV infection. N Engl J Med 319: 889–896PubMedCrossRefGoogle Scholar
  65. Pohl P, Vogl G, Fill H, Rössler H, Zangerle R, Gerstenbrand F (1988) Single photon emission computed tomography in AIDS dementia complex. J Nucl Med 29: 1382–1386PubMedGoogle Scholar
  66. Post MJD, Kursunoglu SJ, Hensley GT, Chan JC, Moskowitz LB, Hoffman TA (1985) Cranial CT in acquired immunodeficiency syndrome: Spectrum of diseases and optimal contrast enhancement technique. AJR 145: 929–940Google Scholar
  67. Poutiainen E, Iivanainen M, Elovaara I, Valle SL, Lähdevirta J (1988) Cognitive changes as early signs of HIV infection. Acta Neurol Scand 78: 49–52PubMedCrossRefGoogle Scholar
  68. Price RW, Brew BJ (1988) The AIDS dementia complex. J Infect Dis 158:1079–1083 Przedborski S, Liesnard C, Voordecker P et al. (1988) Inflammatory demyelinating polyradi-culoneuropathy associated with human immu-nodeficiency virus infection. J Neurol 235: 359–361Google Scholar
  69. Pumarola-Sune T, Navia BA, Cordon-Cardo C, Cho ES, Price RW (1987) HIV antigen in the brains of patients with the AIDS dementia complex. Ann Neurol 21: 490–496PubMedCrossRefGoogle Scholar
  70. Resnick L, di Marzo-Veronese F, Schüpback J et al. (1985) Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. N Engl J Med 313: 1498–1504PubMedCrossRefGoogle Scholar
  71. Resnick L, Berger JR, Shapshak P, Tourtellotte WW (1988) Early penetration of the blood-brain-barrier by HIV. Neurology 38:9–14 Rosenblum LM, Levy RM, Bredesen DE, So YT, Wara W, Ziegler JL (1988) Primary central nervous system lymphomas in patients with AIDS. Ann Neurol 23 [Suppl]: 13–16CrossRefGoogle Scholar
  72. Schielke E, Pfister HW, Einhäupl KM (1989) Peripheral facial nerve palsy associated with HIV infection. Lancet 1: 553–554PubMedCrossRefGoogle Scholar
  73. Schmitt FA, Bigley JW, McKinnis R, Logue PE, Evans RW, Drucker JL (1988) Neuropsychological outcome of zidovudine ( AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med 319: 1573–1578Google Scholar
  74. Shaw GM, Harper ME, Hahn BH et al. (1985) HTLV-III infection in brains of children and adults with encephalopathy. Science 227: 177–182PubMedCrossRefGoogle Scholar
  75. Smith T, Jakobsen J, Gaub J, Helweg-Larsen S, Trojaborg W (1988) Clinical and electrophy-siological studies of human immunodeficiency virus-seropositive men without AIDS. Ann Neurol 23: 295–297PubMedCrossRefGoogle Scholar
  76. Snider WD, Simpson DM, Nielsen S, Gold J, Metroka CE, Posner JB (1983) Neurological complications of acquired immune deficiency syn-drome: Analysis of 50 patients. Ann Neurol 14: 403–418PubMedCrossRefGoogle Scholar
  77. Simpson DM, Bender AN (1988) Human immunodeficiency virus-associated myopathy: Analysis of 11 patients. Ann Neurol 24: 79–84PubMedCrossRefGoogle Scholar
  78. So YT, Beckstead JH, Davis RL (1986) Primary central nervous system lymphoma in acquired immune deficiency syndrome: A clinical and pathological study. Ann Neurol 20: 566–572Google Scholar
  79. Stern JJ, Hartman BJ, Sharkey P, Rowland V, Squires KE, Murray HW, Graybill JR (1988) Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: Experience with 22 patients. Am J Med 85: 477–480PubMedCrossRefGoogle Scholar
  80. Tervo T, Elovaara I, Karli H, Valle SL, Suni J, Lähdevirta J, Iivanainen M (1986) Abnormal ocular motility as early sign of CNS involvement in HIV infection. Lancet 11: 512CrossRefGoogle Scholar
  81. Vazeux R, Brousse N, Jarry A et al. (1987) AIDS subacute encephalitis. Identification of infected cells. Am J Pathol 126: 403–410Google Scholar
  82. Villa A, Foresti V, Confalonieri F (1987) Autonomic HIV infection and neuropathy. Lancet 11: 915CrossRefGoogle Scholar
  83. Vishnubakat M, Kaplan M, Farber B, Beresford HR (1988) Effect of azidothymidine (AZT) on peripheral neuropathy of HIV-infected patients: A prospective study. Neurology 38 [Suppl 1]: 241Google Scholar
  84. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MBA (1986) Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sei 83: 7089–7093CrossRefGoogle Scholar
  85. Wong R, Carr G, Kaplan L (1988) Incidence of peripheral neuropathy in patients with group IV HIV infection on zidovudine therapy. IVth International Conference on AIDS. Stockholm 1988Google Scholar
  86. Yarchoan R, Thomas RV, Grafman J et al. (1988) Longterm administration of 3′-azido-2′,3′-dideoxythmidine of patients with AIDS-related neurological disease. Ann Neurol 23 [Suppl]: 82–87CrossRefGoogle Scholar
  87. Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ (1986) Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Ann Int Med 104: 234–240PubMedGoogle Scholar

Copyright information

© Springer-Verlag, Berlin, Heidelberg New York 1989

Authors and Affiliations

  • Karl M. Einhäupl
  • Eva Schielke

There are no affiliations available

Personalised recommendations